Abstract

Ti6Al4V scaffolds with pore sizes between 300 and 600µm are deemed suitable for bone tissue engineering. However, a significant proportion of human bone pores are smaller than 300µm, playing a crucial role in cell proliferation, differentiation, and bone regeneration. Ti6Al4V scaffolds with these small-sized pores are not successfully fabricated, and their cytocompatibility remains unknown. The study presentsa novel ink formula specifically tailored for fabricating Ti6Al4V scaffolds featuring precise and unobstructed sub-300µm structural pores, achieved by investigating the rheological properties and printability of five inks containing 60-77.5vol% Ti6Al4V powders and bisolvent binders. Ti6Al4V scaffolds with 50-600µm pores are fabricated via direct ink writing and subjected to in vitro assays withMC3T3-E1 and bone marrow mesenchymal stem cells. The 100µm pore-sized scaffolds exhibit the highest cell adhesion and proliferation capacity based on live/dead assay, FITC-phalloidin/4',6-diamidino-2-phenylindole staining, and cell count kit 8 assay. The alizarin red staining, real-time quantitative PCR assay, and immunocytochemical staining demonstrate the superior osteogenic differentiation potential of 100 and 200µm pore-sized scaffolds. The importance of sub-300µm structrual pores is highlighted, redefining the optimal pore size for Ti6Al4V scaffolds and advancing bone tissue engineering and clinical medicine development.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.